alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document

Exhibit 10.10(e)


AMENDMENT NUMBER FOUR TO THE
UNITED STATES CELLULAR CORPORATION
2013 LONG-TERM INCENTIVE PLAN




WHEREAS, United States Cellular Corporation, a Delaware corporation (the “Company”) has adopted and maintains the United States Cellular Corporation 2013 Long-Term Incentive Plan (the “Plan”) for the benefit of certain employees;
WHEREAS, pursuant to Section 8.2 of the Plan, the Board of Directors of the Company (the “Board”) may amend the Plan as it shall deem advisable, subject to any requirement of shareholder approval as specified in the Plan, including under applicable law or the principal national stock exchange on which the Common Shares of the Company are then traded;
WHEREAS, the Board desires to amend the Plan to expand the types of bonuses eligible for deferral under the Plan’s phantom stock program and in certain administrative respects; and
WHEREAS, such amendment is not subject to any required shareholder approval.
NOW, THEREFORE, BE IT RESOLVED, that the Plan hereby is amended, effective as of December 3, 2021, as follows:
1.The first sentence of Section 2.7 hereby is amended to read as follows:
“Bonus Year” shall mean each calendar year for which a bonus is payable (whether the bonus was earned during all or a portion of such calendar year).
2.Section 7.1 hereby is amended in its entirety to read as follows:
7.1    Bonus Deferral.  The Committee may, in its discretion, permit an employee selected by the Committee to make an irrevocable election (i) not to receive currently any whole percentage of his or her gross bonus payment (whether related to an annual bonus, quarterly bonus or such other bonus as permitted by the Committee) and (ii) to have an amount equal to such percentage credited to the employee’s Deferred Compensation Account as of the date on which the bonus check is to be issued (such election, a “deferral election”).  Except as otherwise permitted by law and the Committee, an employee’s deferral election shall be made on or before the last day of the calendar year immediately preceding the Bonus Year.  Bonus amounts credited to the employee’s Deferred Compensation Account pursuant to this Section 7.1 (as adjusted for deemed investment returns pursuant to Section 7.3) shall be 100% vested at all times and shall be subject to the terms and conditions set forth in this Article VII and such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem advisable.
3.Section 7.2(b) hereby is amended to delete the word “annual” the second and third times it appears therein.
4.Section 7.3 hereby is amended to delete the phrase “whole and fractional” as it appears therein.


* * * * * *




IN WITNESS WHEREOF, the undersigned has executed this Amendment Number Four as of this third day of December, 2021.


									
	UNTIED STATES CELLULAR CORPORATION	
			
	By:	/s/ Laurent Therivel	
		Laurent Therivel	
	Its:	President and Chief Executive Officer
### IN THE

TENTH COURT OF APPEALS

No. 10

- 12

- 00055

- CV

MARC GARZA AND CHELS EA COULSON

, Appellant s

v.

MASSAGE ENTERPRISES, LLC

, Appellee

From the 272nd District Court

Brazos County, Texas

Trial Court No. 11

- 003064

- CV

- 272

MEMORANDUM OPINION

Marc Garza and Chelsea Coulson appeal from a temporary injunction signed on

January 13, 2012. Their brief in this appeal was due June 11, 2012. No brief was filed.

By letter dated June 22, 2012, the Clerk of this Court warned Garza and Coulson that

their app eal would be dismissed for want of prosecution unless, within 21 days from

the date of the letter, Garza and Coulson or any party wishing to continue the appeal

filed a response showing grounds for continuing the appeal. More than 21 days have

passed, and no response has been filed.Garza v. Massage Enterprises Page 2

Accordingly, this appeal is dismissed. T EX

. R. A PP

. P. 42.3(b).

TOM GRAY

Chief Justice

Before Chief Justice Gray,

Justice Davis, and

Justice Scoggins

Appeal dismissed

Opinion delivered and filed August 2, 2012

[CV06]
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

MARCELO LUNA-MASTACHE,

 Petitioner,

 v.

ERIC H. HOLDER, Jr., Attorney General,

 Respondent.

No. 10-73824

Agency No. A093-446-440

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted February 21, 2012** 

Before: FERNANDEZ, McKEOWN, and BYBEE, Circuit Judges.

Marcelo Luna-Mastache, a native and citizen of Mexico, petitions for review

of the Board of Immigration Appeals’ (“BIA”) order dismissing his appeal from an

immigration judge’s removal order. We have jurisdiction under 8 U.S.C. § 1252. 

We review de novo questions of law, Gutierrez v. Holder, 662 F.3d 1083, 1086

FILED

FEB 24 2012

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 10-73824

(9th Cir. 2011), and we deny the petition for review.

Luna-Mastache contends that the government’s evidence of his alienage

should not have been admitted at his removal hearing because it was protected by

the confidentiality provision set forth at 8 U.S.C. § 1255a(c)(5)(A)(i). Contrary to

his contention, the BIA correctly concluded that the evidence was not protected

because it was drawn from Luna-Mastache’s employment verification documents,

and was not “information furnished by” Luna-Mastache in his legalization

application. 8 U.S.C. § 1255a(c)(5)(A)(i); see also id. § 1101(a)(3) (“The term

‘alien’ means any person not a citizen or national of the United States.”).

Luna-Mastache’s contention that 8 U.S.C. § 1252(a)(2)(B) violates due

process and separation of powers by impinging on his fundamental right to family

unity is foreclosed by De Mercado v. Mukasey, 566 F.3d 810, 816 (9th Cir. 2009).

PETITION FOR REVIEW DENIED.
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
This schedule  contains summary  financial  information  extracted from the
financial  statements of Ray Ellison Mortgage  Acceptance Corp. at September 30,
1996 and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<CIK>                         754591
<NAME>                        Ray Ellison Mortgage Acceptance Corp.
<MULTIPLIER>                  1
<CURRENCY>                    Dollar
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>               DEC-31-1996
<PERIOD-START>                  JAN-01-1996
<PERIOD-END>                    SEP-30-1996
<EXCHANGE-RATE>                 1
<CASH>                          56,066
<SECURITIES>                    397,749,082
<RECEIVABLES>                   2,580,676
<ALLOWANCES>                    0
<INVENTORY>                     0
<CURRENT-ASSETS>                2,636,742
<PP&E>                          0
<DEPRECIATION>                  0
<TOTAL-ASSETS>                  419,418,150
<CURRENT-LIABILITIES>           2,536,063
<BONDS>                         426,689,000
<PREFERRED-MANDATORY>           0
<PREFERRED>                     0
<COMMON>                        10,000
<OTHER-SE>                      (9,816,913)
<TOTAL-LIABILITY-AND-EQUITY>    419,418,150
<SALES>                         0
<TOTAL-REVENUES>                22,965,559
<CGS>                           0
<TOTAL-COSTS>                   24,761,161
<OTHER-EXPENSES>                281,075
<LOSS-PROVISION>                0
<INTEREST-EXPENSE>              22,590,531
<INCOME-PRETAX>                 552,183
<INCOME-TAX>                    276,305
<INCOME-CONTINUING>             275,878
<DISCONTINUED>                  0
<EXTRAORDINARY>                 0
<CHANGES>                       0
<NET-INCOME>                    275,878
<EPS-PRIMARY>                   27.58
<EPS-DILUTED>                   27.58
        

</TABLE>
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 06-7496 

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

versus

JUAN GONZALEZ GOMEZ, a/k/a Isidre Enrique

German-Campos, a/k/a Bossman,

Defendant - Appellant.

Appeal from the United States District Court for the Western

District of North Carolina, at Asheville. Lacy H. Thornburg,

District Judge. (1:01-cr-00010-2; 1:03-cv-00092)

Submitted: November 21, 2006 Decided: December 4, 2006

Before TRAXLER and DUNCAN, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Dismissed by unpublished per curiam opinion.

Juan Gonzalez Gomez, Appellant Pro Se. Thomas Richard Ascik,

OFFICE OF THE UNITED STATES ATTORNEY, Asheville, North Carolina,

for Appellee.

Unpublished opinions are not binding precedent in this circuit. 
- 2 -

PER CURIAM:

Juan Gonzales Gomez seeks to appeal the district court’s

order treating his Fed. R. Civ. P. 60(b) motion as a successive 28

U.S.C. § 2255 (2000) motion, and dismissing it on that basis. The

order is not appealable unless a circuit justice or judge issues a

certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000);

Reid v. Angelone, 369 F.3d 363, 369 (4th Cir. 2004). A certificate

of appealability will not issue absent “a substantial showing of

the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2)

(2000). A prisoner satisfies this standard by demonstrating that

reasonable jurists would find that any assessment of the

constitutional claims by the district court is debatable or wrong

and that any dispositive procedural ruling by the district court is

likewise debatable. Miller-El v. Cockrell, 537 U.S. 322, 336-38

(2003); Slack v. McDaniel, 529 U.S. 473, 484 (2000); Rose v. Lee,

252 F.3d 676, 683-84 (4th Cir. 2001). We have independently

reviewed the record and conclude that Gomez has not made the

requisite showing. Accordingly, we deny a certificate of

appealability and dismiss the appeal.

Additionally, we construe Gomez’s notice of appeal and

informal brief as an application to file a second or successive

motion under 28 U.S.C. § 2255. United States v. Winestock, 340

F.3d 200, 208 (4th Cir. 2003). In order to obtain authorization to

file a successive § 2255 motion, a prisoner must assert claims
- 3 -

based on either: (1) a new rule of constitutional law, previously

unavailable, made retroactive by the Supreme Court to cases on

collateral review; or (2) newly discovered evidence, not previously

discoverable by due diligence, that would be sufficient to

establish by clear and convincing evidence that, but for

constitutional error, no reasonable factfinder would have found the

movant guilty of the offense. 28 U.S.C. §§ 2244(b)(2), 2255

(2000). Gomez’s claims do not satisfy either of these criteria.

Therefore, we deny authorization to file a successive § 2255

motion. 

We dispense with oral argument because the facts and

legal contentions are adequately presented in the materials before

the court and argument would not aid the decisional process.

DISMISSED
John L. LENTZ, Jr., M.D., Appellant, v. DEPARTMENT OF HEALTH, Appellee.

No. 1D17-334

District Court of Appeal of Florida, First District.

January 26, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 32

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C.
SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel C. Montano, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that
the Annual Report of CardioVascular BioTherapeutics, Inc. (the Company) on Form 10-K/A for the fiscal year ended December 31, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934 and that information contained in such Annual Report on Form 10-K/A fairly presents in all material respects the financial condition and results of operations of the Company.



|                    |  |              |  |                                                           
|------------------- |  | ------------ |  | ----------------------------------------------------------
|Date: June 26, 2007 |  | By:          |  | /s/    DANIEL C.
MONTANO                                  
|                    |  | Name: Title: |  | Daniel C. Montano Co-President and Chief Executive Officer

I, Mickael A. Flaa, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of CardioVascular BioTherapeutics, Inc. (the Company) on Form 10-K/A for the fiscal year ended December 31, 2006 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K/A fairly presents in all material respects the financial condition and results of operations of the Company.



|                    |  |              |  |                                        
|------------------- |  | ------------ |  | ---------------------------------------
|Date: June 26, 2007 |  | By:          |  | /s/    MICKAEL A.
FLAA                 
|                    |  | Name: Title: |  | Mickael A. Flaa Chief Financial Officer

Signed originals of these written statements required by Section 906 of the
Sarbanes-Oxley Act of 2002 have been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

These certifications accompany the Form 10-K/A to which they relate, are not deemed filed with the Securities and Exchange Commission and are not to
be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of this Form 10-K/A, irrespective of any general incorporation language
contained in such filing.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2566 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2566

To suspend temporarily the duty on certain plastic stylus pens for use 
                               with toys.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

Mrs. Feinstein introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To suspend temporarily the duty on certain plastic stylus pens for use 
                               with toys.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN PLASTIC STYLUS PENS FOR USE WITH TOYS.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00       Plastic stylus     Free         No change        No change        On or before 12/  ''.
                        pen with or                                                        31/2015.......
                        without
                        attachment cord
                        designed for use
                        with electronic
                        drawing toys,
                        electronic games
                        or educational
                        toys or devices
                        (provided for as
                        `parts' in
                        heading 8543,
                        9503 or 9504)....

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
IN RE: BAR ADMISSIONS CFN-296758

NO. 2018-BA-0417

Supreme Court of Louisiana.

April 16, 2018

Motion to file untimely petition denied. Petition for admission to the bar not considered. Supreme Court Rule XVII, § 9(B). Pursuant to Supreme Court Rule XIX, § 9(D)(13), petitioner may not seek admission until one year after October 6, 2017.

JOHNSON, C.J., would grant and consider the petition.

HUGHES, J., would grant and consider the petition.
Exhibit 32.1

WRITTEN STATEMENT OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER AND THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350

Solely for the
purpose of complying with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned President and the Chief Financial Officer of Veri-Tek International, Corp. (the Company), hereby
certify that to the best of our knowledge the Annual Report of the Company on Form 10-K for the year ended December 31, 2005 (the Report) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of
1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|       |  |                                                                              
|------ |  | -----------------------------------------------------------------------------
|By:    |  | /s/ DONALD F. BROWN                                                          
|Name:  |  | Donald F. Brown                                                              
|Title: |  | President and Chief Operating Officer                                        
|       |  | (Principal Executive Officer of Veri-Tek International,
Corp.)               
|       | 
|By:    |  | /s/ PATRICK T. FLYNN                                                         
|Name:  |  | Patrick T. Flynn                                                             
|Title: |  | Vice President, Finance                                                      
|       |  | (Principal Financial and Accounting Officer of Veri-Tek
International, Corp.)



56
March 19, 2013

Mr. John Varley

Senior Vice President and General Counsel Virgin America, Inc. 555 Airport Boulevard, Suite 500 Burlingame, CA 94010

Dear Mr. Varley:

This is in response to your February 28, 2013 letter sent to the public docket (No. FAA-2013-0224) petitioning the Federal Aviati on Administration on behalf of Virgin America, Inc., for an exemption from § 121.803(c)(3) of Title 14, Code of Federal Regulations (14 CFR). That exemption, if granted, would provide relief from the requirement to include Dextrose in an Emergency Medical Kit (EMK).

On March 14, 2013, the FAA issued Exemption No. 10721 (copy enclosed) to Airlines for

America, National Air Carrier Association, Re gional Airline Association, its members, and similarly situated air carriers.

Because the relief you seek is now covered under Exemption No. 10721, we will take no further action on your petition.

Sincerely,

/s/ Ida M. Klepper Manager, Airmen and Airspace Rules Division

Enclosure
**EXHIBIT
      32.1**





**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Sierra Health Services, Inc. (the
      Company) on Form 10-Q for the period ending September 30, 2006 as filed with
      the
      Securities and Exchange Commission on the date hereof (the Report), I, Anthony
      M. Marlon, M.D., Chief Executive Officer of the Company, certify, pursuant
      to 18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
      Act of 2002, that:




The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.








/s/Anthony M. Marlon, M.D.


Anthony
      M. Marlon, M.D.


Chief
      Executive Officer


October
      25, 2006
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
Registrant is a limited partnership which invests in real estate and real
estate joint ventures.  In accordance with industry practice, its balance
sheet is unclassified.  For full information, refer to the accompanying
unaudited financial statements.
</LEGEND>
<CIK> 0000752744
<NAME> DEAN WITTER REALTY INCOME PARTNERSHIP II, L.P.
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          OCT-31-1996
<PERIOD-END>                               JAN-31-1996
<CASH>                                      18,509,991
<SECURITIES>                                         0
<RECEIVABLES>                                2,568,577
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             113,733,795<F1>
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                 104,323,851<F2>
<TOTAL-LIABILITY-AND-EQUITY>               113,733,795<F3>
<SALES>                                              0
<TOTAL-REVENUES>                             4,707,744<F4>
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            15,137,409
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (10,429,665) 
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (10,429,665)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (10,429,665)<F5>
<EPS-PRIMARY>                                    (53.03)<F6>
<EPS-DILUTED>                                        0
<FN>
<F1>In addition to cash and receivables, total assets include net investments
in real estate of $87,677,596, investment in joint venture of $2,703,471, 
net deferred leasing commissions of $2,052,354 and other assets of $221,806.
<F2>Other Stockholders' Equity represents partners' capital.
<F3>Liabilities include accounts payable and accrued liabilities of
$778,878, minority interest in joint venture of $8,402,653, and other
liabilities of $228,413.
<F4>Total revenue includes rent of $4,327,918, equity in earnings of joint
venture of $71,417, and interest and other revenues of $308,409.
<F5>Net loss includes loss on impairment of real estate of $11,870,000.
<F6>Represents net loss per Unit of limited partnership interest.
</FN>
        

</TABLE>